The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer

BACKGROUND: N-Acetylgalactosaminyltransferases (GALNTs), the enzymes that initiate mucin-type O-glycosylation, are closely associated with tumor occurrence and progression. However, a comprehensive analysis of GALNTs in non-small cell lung cancer (NSCLC) is lacking. METHODS: The expression profiles...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qing, Tian, Tian, Leng, Yahui, Tang, Yuanhui, Chen, Shuang, Lv, Yueyao, Liang, Jingyin, Liu, Yanni, Liu, Tianhui, Shen, Li, Dong, Xiaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440866/
https://www.ncbi.nlm.nih.gov/pubmed/36058918
http://dx.doi.org/10.1186/s11658-022-00378-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440866/
https://www.ncbi.nlm.nih.gov/pubmed/36058918
http://dx.doi.org/10.1186/s11658-022-00378-w

Ejemplares similares